We can buy this stock at 28,50$, In this post we are going to talk about the listed company Genmab AS, its leaders are Anthony Mancini (Chief Operating Officer & Executive Vice President), Anthony Pagano (Chief Financial Officer & Executive Vice President), Jan G. J. van de Winkel (President & Chief Executive Officer), Tahamtan Ahmadi (Chief Medical Officer & Executive Vice President), they lead it to work in Biotechnology: Commercial Physical & Biological Resarch especially in the Europe region.
Today this action begins with yesterday's closing price, desconocido$.
The current range on the same day is from 28,30$ - 28,50$, with a percentage difference of 28,40$ quite wide that helps to be able to do day trading.
He earns an annual income of desconocido.
The last registered opening is of desconocido.
To detect if it is a good time to enter or exit a stock, many traders use the lowest and highest values of the last 52 weeks. In this action, prices have moved between 0,00$ and 0,00$.
Earnings per share, or EPS, is a value also used to assess whether a company has obtained sufficient net profits for the number of shares it has for sale. In this case it is [BPA], but it must be taken into account that there may have been increases or decreases in capital that influence the value.
Buscar
